No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials

Gale, Rosemary E., Popa, Teodora, Wright, Melissa, Khan, Naeem, Freeman, Sylvie D., Burnett, Alan K., Russell, Nigel H., Hills, Robert and Linch, David C. 2018. No evidence that CD33 splicing SNP impacts the response to GO in younger adults with AML treated on UK MRC/NCRI trials. Blood 131 (4) , pp. 468-471. 10.1182/blood-2017-08-802157

Preview

PDF - Accepted Post-Print Version Download (631kB) | Preview

Item Type:	Article
Date Type:	Published Online
Status:	Published
Schools:	Centre for Trials Research (CNTRR) Medicine
Publisher:	American Society of Hematology
ISSN:	0006-4971
Date of First Compliant Deposit:	13 June 2018
Date of Acceptance:	1 December 2017
Last Modified:	19 Oct 2019 03:57
URI:	http://orca.cf.ac.uk/id/eprint/112239

Citation Data

Cited 7 times in Scopus. View in Scopus. Powered By Scopus® Data

Actions (repository staff only)

Edit Item